Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
Article Information
History
- December 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Erica Simons1,*,
- Birgit Nikolay1,*,$,
- Pascal Ouedraogo1,
- Estelle Pasquier1,
- Carlos Tiemeni3,
- Ismael Adjaho2,
- Colette Badjo2,
- Kaouther Chamman1,
- Mariam Diomandé2,
- Mireille Dosso4,
- Moussa Doumbia4,
- Yves Asuni Izia3,
- Hugues Kakompe5,
- Anne Marie Katsomya3,
- Vicky Kij5,
- Viviane Kouakou Akissi4,
- Christopher Mambula3,
- Placide Mbala-Kingebeni6,
- Jacques Muzinga7,
- Basile Ngoy5,
- Lou Penali4,
- Alessandro Pini1,
- Klaudia Porten1,
- Halidou Salou1,
- Daouda Sevede4,
- Francisco Luquero1 and
- Etienne Gignoux1
- 1Epicentre, Paris, France
- 2Médecins Sans Frontières, Abidjan, Cote d’Ivoire
- 3Médecins Sans Frontières, Paris, France
- 4Institut Pasteur Cote d’Ivoire, Abidjan, Cote d’Ivoire
- 5Ministry of Health, Democratic Republic of the Congo
- 6INRB, Democratic Republic of the Congo
- 7Laboratoire National de Lubumbashi, Democratic Republic of the Congo
- ↵$Corresponding author; email: birgit.nikolay{at}epicentre.msf.org
↵* These authors contributed equally to the study
Posted December 13, 2022.
Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d’Ivoire
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos